Procter & Gamble (NYSE: PG) director reports 341-share RSU grant and 36,083.677 total shares

Rhea-AI Filing Summary

Procter & Gamble director Joseph Jimenez reported an equity award from the company. On 12/09/2025, he acquired 341 shares of common stock, shown at a price of $0, reflecting a grant of Restricted Stock Units under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Following this award, he is shown as beneficially owning 36,083.677 shares of Procter & Gamble common stock in direct ownership. The total includes dividend equivalents granted in the form of additional Restricted Stock Units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JIMENEZ JOSEPH

(Last) (First) (Middle)

ONE PROCTER & GAMBLE PLAZA

(Street)

CINCINNATI OH 45202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/09/2025		A		341	A	$0(1)	36,083.677(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

2. Total includes grant of dividend equivalents in the form of Restricted Stock Units.

	/s/ Wednesday Shipp, attorney-in-fact for Joseph Jimenez	12/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Procter & Gamble (PG) report in this Form 4?

Procter & Gamble reported that director Joseph Jimenez received an award of 341 shares of common stock on 12/09/2025, reflected as a grant of Restricted Stock Units under the company’s 2025 Stock and Incentive Compensation Plan.

How many Procter & Gamble (PG) shares does the reporting person beneficially own after this transaction?

After the reported grant, the filing shows that Joseph Jimenez beneficially owns 36,083.677 shares of Procter & Gamble common stock in direct ownership.

What type of equity award did the Procter & Gamble (PG) director receive?

The filing describes the award as Restricted Stock Units granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, with related dividend equivalents also granted as Restricted Stock Units.

Why is the transaction price shown as $0 for the Procter & Gamble (PG) shares?

The $0 price indicates that the 341 shares were acquired through an equity grant of Restricted Stock Units, rather than through a market purchase for cash consideration.

What is the relationship of the reporting person to Procter & Gamble (PG)?

The reporting person, Joseph Jimenez, is identified in the filing as a Director of Procter & Gamble.

Does this Procter & Gamble (PG) Form 4 involve derivative securities?

The section for derivative securities is included in the form, but in the excerpt provided, no specific derivative security transactions are listed with quantities or terms.